Stifel Financial Corp Agenus Inc Transaction History

Stifel Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$1.59 - $2.66 $17,594 - $29,435	-11,066 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$1.59 - $2.42 $1,590 - $2,420	1,000 Added 9.93%	11,066 $23,000
Q1 2018 May 11, 2018	SELL	$3.51 - $6.04 $2,106 - $3,624	-600 Reduced 5.63%	10,066 $47,000
Q4 2017 Feb 14, 2018	BUY	$3.26 - $4.78 $34,771 - $50,983	10,666	10,666 $34,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.